ATE293969T1 - Verwendung von hydroxyeicosatetraensäure für intraokuläre chirurgie - Google Patents

Verwendung von hydroxyeicosatetraensäure für intraokuläre chirurgie

Info

Publication number
ATE293969T1
ATE293969T1 AT01983088T AT01983088T ATE293969T1 AT E293969 T1 ATE293969 T1 AT E293969T1 AT 01983088 T AT01983088 T AT 01983088T AT 01983088 T AT01983088 T AT 01983088T AT E293969 T1 ATE293969 T1 AT E293969T1
Authority
AT
Austria
Prior art keywords
hydroxyeicosatetraenic
acid
intraocular surgery
surgery
intraocular
Prior art date
Application number
AT01983088T
Other languages
English (en)
Inventor
Mutlu Karakelle
Kwan Chan
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Application granted granted Critical
Publication of ATE293969T1 publication Critical patent/ATE293969T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01983088T 2000-10-23 2001-09-27 Verwendung von hydroxyeicosatetraensäure für intraokuläre chirurgie ATE293969T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24250100P 2000-10-23 2000-10-23
PCT/US2001/030212 WO2002034258A1 (en) 2000-10-23 2001-09-21 Use of hydroxyeicosatetraenoic acid derivatives in intraocular surgery

Publications (1)

Publication Number Publication Date
ATE293969T1 true ATE293969T1 (de) 2005-05-15

Family

ID=22915018

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01983088T ATE293969T1 (de) 2000-10-23 2001-09-27 Verwendung von hydroxyeicosatetraensäure für intraokuläre chirurgie

Country Status (11)

Country Link
US (1) US6462082B2 (de)
EP (1) EP1330246B1 (de)
JP (1) JP2004517055A (de)
AT (1) ATE293969T1 (de)
AU (2) AU1454302A (de)
CA (1) CA2419373A1 (de)
DE (1) DE60110449T2 (de)
DK (1) DK1330246T3 (de)
ES (1) ES2237607T3 (de)
PT (1) PT1330246E (de)
WO (1) WO2002034258A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003105831A1 (en) * 2002-06-14 2003-12-24 Alcon, Inc. Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders
US20040002514A1 (en) * 2002-06-14 2004-01-01 Alcon, Inc. Topical use of hydroxyeicosatetraenoic acid compounds to treat psoriasis
GB0411165D0 (en) * 2004-05-19 2004-06-23 Bionovate Ltd Hyaluronic acid containing pharmaceutical or veterinary compounds
TW200940054A (en) * 2007-12-21 2009-10-01 Alcon Res Ltd Intraocular irrigating solutions and methods for treating corneal edema

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409904A (en) * 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
US4868154A (en) 1986-02-19 1989-09-19 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with melanocyte stimulating hormones
US4753945A (en) 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
US4818537A (en) 1986-10-21 1989-04-04 Liposome Technology, Inc. Liposome composition for treating dry eye
US4906467A (en) * 1988-03-24 1990-03-06 New York Medical College Novel, long-duration treatment for glaucoma
US5103840A (en) * 1990-05-07 1992-04-14 Kavoussi Harold P Viscoelastic collagen gel for ophthalmic surgery
DE69326836T2 (de) 1992-04-21 2000-02-24 Schepens Eye Res Inst Androgentherapie am auge beim sjögrensyndrom
US5455265A (en) 1993-02-11 1995-10-03 Allergan, Inc. Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
US5696166A (en) * 1995-10-31 1997-12-09 Yanni; John M. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
DE19853007C2 (de) * 1998-11-17 2000-11-30 Matthias Meyer Hyaluronsäure enthaltende Irrigationslösung für Operationen am Auge
ATE272603T1 (de) 1999-11-09 2004-08-15 Alcon Inc Zusammensetzungen mit hydroxyeicosatetraensäure derivate und verfahren zur verwendung zur behandlung des trockenen auges

Also Published As

Publication number Publication date
JP2004517055A (ja) 2004-06-10
EP1330246B1 (de) 2005-04-27
ES2237607T3 (es) 2005-08-01
DK1330246T3 (da) 2005-08-08
EP1330246A1 (de) 2003-07-30
PT1330246E (pt) 2005-06-30
AU1454302A (en) 2002-05-06
DE60110449D1 (de) 2005-06-02
DE60110449T2 (de) 2005-12-01
WO2002034258A1 (en) 2002-05-02
CA2419373A1 (en) 2002-05-02
US6462082B2 (en) 2002-10-08
AU2002214543B2 (en) 2005-11-17
US20020103257A1 (en) 2002-08-01

Similar Documents

Publication Publication Date Title
ATE303794T1 (de) Zusammensetzungssammlung und kit für intraokuläre chirurgie
DE69521620D1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
EA199900811A1 (ru) Композиция для офтальмологических хирургических операций (варианты) и способ их осуществления
BRPI0418245A (pt) nitróxi-derivados de prostaglandina
NO992492L (no) Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
BR0210241A (pt) Piranoindazóis e seu uso no tratamento de glaucoma
DK1023077T3 (da) Ophthalmisk sammensætning
BR0017163A (pt) Derivados 5-hidróxi-indazol para tratamento do glaucoma
ATE293969T1 (de) Verwendung von hydroxyeicosatetraensäure für intraokuläre chirurgie
BR9712308A (pt) Inibidor de catarata secundária
DE60237003D1 (de) Verwendung von 3-positions-cyclosporin-derivaten für haarwachstum
ATE369856T1 (de) Verfahren zur behandlung von glaukom
DE60135972D1 (de) Orhthalmologische zusammenstellungen zur behandlung von ocularer hypertension
TR200002687T2 (tr) Glikojen içeren oftalmik çözelti
ATE227135T1 (de) Miotische wirkstoffe und hypertonische wirkstoffe enthaltende ophthalmische zusammensetzungen
ATE339445T1 (de) Verwendung von l-carnitin als stabilitsator für proteine
PT1067907E (pt) Solucao para irrigacao ocular
ATE374192T1 (de) 1-(2-m-methansulfonamidophenylethyl)-4-(m- trifluoromethylphenyl)piperazine und ihre akzeptablen pharmazeutischen salze und solvate und ihre verwendung zur behandlung von inkontinenz
BR0215752A (pt) Piranoindazóis e seu uso no tratamento de glaucoma
DE60012163D1 (de) Verwendung von ap-1 aktivatoren zur behandlung von glaukom und erhöhtem augenblutdruck
SE0201374D0 (sv) Pharmaceutical combination
EA200300257A1 (ru) Способ хирургической коррекции астигматизма аксиальным лазерным кератомилезом
UA36501A (uk) Спосіб ступінчастої сінустрабекулектомії

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1330246

Country of ref document: EP

REN Ceased due to non-payment of the annual fee